HIV Prevention Study Using PrEP Should Be Replicated After Success In Australia’s NSW, Researchers Say

The Guardian: Groundbreaking Australian HIV trial should be replicated, researchers say
“High-income countries with people at high risk of HIV should replicate a groundbreaking trial in Australia, which has seen new infections [among men who have sex with men in New South Wales] fall by 25 percent in one year following the rapid rollout of free HIV medication, researchers say. … Professor Andrew Grulich, from the Kirby Institute at UNSW Sydney, led a study that followed … gay and bisexual men … Only two of the men acquired HIV, and neither of those had been taking PrEP as prescribed…” (Davey, 10/17).

Reuters Health: HIV prevention drugs could dramatically cut new infections
“… ‘(This is) a really important study because it documents the benefit of HIV prevention pills at a population level,’ said Dr. Jeffrey D. Klausner of the University of California, Los Angeles, who wasn’t involved in the new research’…” (Carroll, 10/17).

Additional coverage of the PrEP study is available from Bloomberg, CNN, NBC News, and STAT.